LD-2 disclosure · 4th Quarter - Report
BRIDGEBIO PHARMA, INC.
via BRIDGEBIO PHARMA, INC.
Expenses$320Kself-filed spend
Client
- Name
- BRIDGEBIO PHARMA, INC.
- Description
- Biotech company
- Location
- California · United States of America
Registrant
- Firm
- BRIDGEBIO PHARMA, INC.
- Location
- Palo Alto, California, United States of America
Lobbying activities
1 issuePharmacy
Creating Hope Reauthorization Act of 2024 - H.R. 7384 Give Kids a Chance Act of 2024 - H.R. 3433 Creating Hope Reauthorization Act of 2024 - S. 4583 March-in/Bayh-Dole Act Orphan drug policies Scientific EXPERT Act of 2024 - H.R.9979 H.R.9979 - Scientific EXPERT Act of 2024 H.R.10545 - American Relief Act, 2025
LobbyistsAMANDA MALAKOFF · MICHAEL CALVO
Covered position (MICHAEL CALVO): Rep. Taylor (NC-11) Intern, Leg. Correspondent, Leg. Asst. Rep. McHenry (NC-10) Policy Advisor Rep. Gingrey (GA-11) Senior Leg. Asst., Senior Policy Advisor, Leg. Director, Deputy Chief of Staff Rep. Hice (GA-10) Leg. Director
TargetedSENATE · HOUSE OF REPRESENTATIVES